REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/20/2026
Back to search
Official data from USPTO
PLEXOZOME
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
07/20/2026
Trademark type
Word
Nice classes
5
Filing date
10/31/2019
Registration date
07/20/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/20/2021
Last transaction
07/20/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
99
Owner location
Frenchs Forest, AU
Examiner
BEVERLY, JOSETTE MICHELLE
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Pharmako Biotechnologies Pty Limited
Representatives
Alexander Lazouski LAZOUSKI IP LLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Chemical preparations for pharmaceutical purposesfor increasing solubility and the subsequent absorption of the active ingredient of pharmaceuticals; Chemical products for pharmaceutical or medical purposeschemical preparations for increasing solubility and the subsequent absorption of the active ingredient of pharmaceuticals; Dietary supplements; Nutritional supplements; Medicinal food supplements; Food supplements for medical purposes; Vitamins; Vitamin supplements; Vitamin preparations; Dietetic foods for increasing solubility and the subsequent absorption of the active ingredient; Dietetic foods adapted for medical use; Sanitary preparations for medical purposes; Preparations for medical purposesfor increasing solubility and the subsequent absorption of the active ingredient; Chemical preparations for medical purposesfor increasing solubility and the subsequent absorption of the active ingredient of pharmaceuticals; Nutraceutical preparations for therapeutic or medical purposesfor increasing solubility and the subsequent absorption of the active ingredient
Publications
History of USPTO decisions and trademark events.
26 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/20/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/04/2021
PUBO
PUBLISHED FOR OPPOSITION
05/04/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/14/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/29/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/29/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/29/2021
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
03/22/2021
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
11/17/2020
GNSI
INQUIRY TO SUSPENSION E-MAILED
11/17/2020
CNSI
SUSPENSION INQUIRY WRITTEN
11/17/2020
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
10/26/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
04/11/2020
GNSL
LETTER OF SUSPENSION E-MAILED
04/11/2020
CNSL
SUSPENSION LETTER WRITTEN
04/11/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/08/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/08/2020
ALIE
ASSIGNED TO LIE
04/08/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/31/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/13/2020
GNRT
NON-FINAL ACTION E-MAILED
02/13/2020
CNRT
NON-FINAL ACTION WRITTEN
02/13/2020
DOCK
ASSIGNED TO EXAMINER
02/05/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/05/2019
NWAP
NEW APPLICATION ENTERED
11/04/2019
Continuous trademark protection
Get notified about every new filing that threatens PLEXOZOME or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.